The **Anti-Hepatitis B Envelope Antibody (AHBe) - Total** test (also known as the Anti-HBe or HBeAb test) is a crucial blood marker used to monitor and evaluate a Hepatitis B virus (HBV) infection.

This test detects total antibodies produced by the body’s immune system to target the Hepatitis B "e" antigen (HBeAg), a protein associated with active viral replication. A positive or reactive result generally signals "seroconversion"—meaning the immune system is gaining control, viral multiplication is slowing down, and the patient's infectivity (risk of transmitting the virus to others) has significantly decreased. Doctors use it alongside other HBV tests to determine the infection stage and assess treatment success.